Childhood Cancer Therapeutic Catalyst

This scheme aims to de-risk early therapeutic opportunities to facilitate further drug discovery activity.

 Activity that would be considered eligible for support through this award includes:

• deconvolution and validation of novel targets and pathways
• novel therapeutic approaches to validated targets
• development of platforms, assays and screens to identify novel therapeutics
• drug discovery feasibility

Funding: £250,000 total 

Duration: 18 months 

Research Authority due date:23.1.25

Preliminary submission (required) due date: 31.1.25

Final proposal due date: 25.4.25